Viewing StudyNCT04789096



Ignite Creation Date: 2024-05-06 @ 3:52 PM
Last Modification Date: 2024-10-26 @ 1:59 PM
Study NCT ID: NCT04789096
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2021-03-01

Brief Title: Tucatinib Together With Pembrolizumab and Trastuzumab
Sponsor: Breast Cancer Trials Australia and New Zealand
Organization: Breast Cancer Trials Australia and New Zealand

Organization Data

Organization: Breast Cancer Trials Australia and New Zealand
Class: OTHER
Study ID: BCT 2102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Breast Cancer Trials Australia and New Zealand
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators